Down-regulation of DOC-2 in colorectal cancer points to its role as a tumor suppressor in this malignancy

Diseases of the Colon and Rectum

Volumn 45, Issue 9, 2002, Pages 1242-1248

  Kleeff, Jörg ^a   Huang, Yong ^a   Mok, Samuel C ^a   Zimmermann, Arthur ^a   Friess, Helmut ^a   Büchler, Markus W ^a  

^a UNIVERSITY OF HEIDELBERG   (Germany)

Author keywords

Colorectal cancer; DOC 2; Tumor suppressor gene

Indexed keywords

GROWTH FACTOR; RAS PROTEIN;

ADULT; AGED; ARTICLE; CANCER INHIBITION; CANCER MORTALITY; CHORIOCARCINOMA; COLORECTAL CANCER; CONTROLLED STUDY; DOC 2 GENE; DOWN REGULATION; FEMALE; GENE EXPRESSION REGULATION; GENE LOSS; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; IMMUNOREACTIVITY; IN SITU HYBRIDIZATION; LIVER METASTASIS; LYMPH NODE METASTASIS; MALE; MITOGENICITY; NORTHERN BLOTTING; OVARY CANCER; SIGNAL TRANSDUCTION; TUMOR SUPPRESSOR GENE;

ADAPTOR PROTEINS, SIGNAL TRANSDUCING; ADAPTOR PROTEINS, VESICULAR TRANSPORT; ADULT; AGED; BLOTTING, NORTHERN; COLORECTAL NEOPLASMS; DOWN-REGULATION; FEMALE; GENES, TUMOR SUPPRESSOR; HUMANS; IMMUNOENZYME TECHNIQUES; IN SITU HYBRIDIZATION; LIVER NEOPLASMS; LYMPHATIC METASTASIS; MALE; MIDDLE AGED; PROTEINS; STATISTICS, NONPARAMETRIC;

EID: 0036734416     PISSN: 00123706     EISSN: None     Source Type: Journal    
DOI: 10.1007/s10350-004-6399-2     Document Type: Article

References (33)

1. A genetic model for colorectal tumorigenesis
2. Genetics, natural history, tumor spectrum, and pathology of hereditary nonpolyposis colorectal cancer: An updated review
3. The human mutator gene homolog MSH2 and its association with hereditary nonpolyposis colon cancer
4. Molecular biology of colon polyps and colon cancer
5. Molecular biology of colorectal cancer
6. Genetic analysis of multiple synchronous lesions of the colon adenoma-carcinoma sequence
7. Somatic mutation rate of the APC gene
8. The many faces of the tumor suppressor gene APC
9. Reduced expression of the metastasis suppressor gene KAI1 in advanced colon cancer and its metastases
10. Overexpression of ICAM-1, VCAM-1 and ELAM-1 might influence tumor progression in colorectal cancer
11. Apoptosis inhibiting factor Bcl-xL might be the crucial member of the Bcl-2 gene family in colorectal cancer
12. Increased expression of erbB3 in colorectal cancer is associated with concomitant increase in the level of erbB2
13. Sequence, genomic structure, and chromosomal assignment of human DOC-2
14. Structure, sequence, and promoter analysis of human disabled-2 gene (dab2)
15. Molecular cloning of differentially expressed genes in human epithelial ovarian cancer
16. Cloning of a novel phosphoprotein regulated by colony-stimulating factor 1 shares a domain with the Drosophila disabled gene product
17. A phosphotyrosine interaction domain
18. An alternative to SH2 domains for binding tyrosine-phosphorylated proteins
19. Identification of a ten-amino acid proline-rich SH3 binding site
20. Disabled-2 (Dab2) is an SH3 domain-binding partner of Grb2
21. Disabled-2 inactivation is an early step in ovarian tumorigenicity
22. DOC-2, a candidate tumor suppressor gene in human epithelial ovarian cancer
23. DOC-2/hDab2, a candidate tumor suppressor gene involved in the development of gestational trophoblastic diseases
24. Colon cancer screening
25. Cancer statistics, 1997
26. Recent developments in molecular biology, screening, and treatment of colorectal cancer
27. Enhanced expression of transforming growth factor beta isoforms in pancreatic cancer correlates with decreased survival
28. Enhanced expression of the type II transforming growth factor beta receptor in human pancreatic cancer cells without alteration of type III receptor expression
29. Doc-2/hDab2 expression is up-regulated in primary pancreatic cancer but reduced in metastasis
30. Regulation of rat DOC-2 gene during castration-induced rat ventral prostate degeneration and its growth inhibitory function in human prostatic carcinoma cells
31. The expression of colorectal carcinoma-associated antigens in the normal colonic mucosa. An immunohistochemical analysis of regional distribution
32. Differential reactivity of monoclonal antibodies with human colon adenocarcinomas and adenomas
33. The role of DOC-2/DAB2 protein phosphorylation in the inhibition of AP-1 activity. An underlying mechanism of its tumor-suppressive function in prostate cancer